Choreoathetosis and deep vein thrombosis : an unusual presentation of proteinase 3 antineutrophil cytoplasmic antibodies‐ associated vasculitis

2021 ◽  
Vol 51 (11) ◽  
pp. 1973-1974
Author(s):  
Andrew P. Maw ◽  
Raymond Chan ◽  
Tracey L. Putt
2009 ◽  
Vol 149A (4) ◽  
pp. 698-701 ◽  
Author(s):  
Michael J. Lipinski ◽  
Shawn E. Lipinski ◽  
Sanjay Kripalani ◽  
Lindsay D. Friesen ◽  
Brian S. Uthlaut ◽  
...  

Author(s):  
Sepehr Sahraiyan ◽  
Mahsa Abbaszadeh ◽  
Pouyan Aminishakib ◽  
Rastegar Rahmani Tanha ◽  
Sahar Karimpour Reyhan

Non-Hodgkin’s B-cell lymphoma is a hematological condition with different types based on clinical presentation, pathological features, and therapeutic response, like Diffuse Large B-cell Lymphoma (DLBCL), follicular lymphoma, and Chronic Lymphocytic Leukemia (CLL). We report A 33-year-old male presented with a complaint of unilateral leg swelling, firstly supposed to be a Deep Vein Thrombosis (DVT); however, in multiple Doppler ultrasonography, DVT was ruled out. The patient’s precise history revealed a swollen mass in the left knee region for two months that slowly enlarged and was confirmed with a physical examination. Doppler ultrasonography of the lower extremities conducted in our center presented no sign of deep vein thrombosis; however, it demonstrated some complex conglomerate lymph nodes in the left inguinal compressing the ipsilateral femoral and iliac vein. It also revealed bulky adenopathy, with a 95×65 mm left knee mass. The performed biopsy reported the existence of malignant lymphoma, suggesting the existence of DLBCL. Consequently, he was referred to a hematology/oncology department for appropriate treatment. This unusual presentation of DLBCL and the importance of noticing an accurate history taking and physical examination, instead of conducting unnecessary paraclinical tests (several Doppler ultrasonography in this case), have led us to report this case.


2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Chandur Bhan ◽  
Nimarta Bheesham ◽  
Fnu Shakuntulla ◽  
Monica Sharma ◽  
Chenyu Sun ◽  
...  

Author(s):  
Anne Manjalee Liyanage ◽  
Tahir Shafiq ◽  
Vitthal Ramchandra Wadekar ◽  
Naveed Sultan ◽  
Fares Abdulla

1998 ◽  
Vol 79 (03) ◽  
pp. 517-519 ◽  
Author(s):  
Stephane Heymans ◽  
Raymond Verhaeghe ◽  
Luc Stockx ◽  
Désiré Collen

SummaryThe feasibility of catheter-directed thrombolysis with recombinant staphylokinase was evaluated in six selected patients with deep vein thrombosis. The patients underwent intrathrombus infusion of recombinant staphylokinase (2 mg bolus followed by a continuous infusion of 1 mg/h). Heparin was given via the catheter as a bolus (5000 U) and as a continuous infusion (1000 U/h). Complete lyis was obtained in five patients and partial lysis in one patient. Complications consisted of minor bleeding in four subjects. Symptomatic reocclusion occurred in one. Debulking of the thrombus mass by a high speed rotating impeller (n = 1) and stenting (n = 3) were used as additional interventions. An underlying anatomical abnormality was present in two patients. Long term follow up revealed normal patency in all patients and normal valve function in four patients. Symptomatic venous insufficiency with valve dysfunction was present in the two with a second thrombotic episode.Thus catheter-directed infusion of recombinant staphylokinase in patients with deep vein thrombosis appears feasible and may be associated with a high frequency of thrombolysis. Larger studies to define the clinical benefit of this treatment appear to be warranted.


Sign in / Sign up

Export Citation Format

Share Document